ALYSSA C YOUNGMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health MENDHAM, NJ NPI 1174091441
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health NJ Exact Sciences Corporation All categories
General Payments — all program years on this page
$499.05
- Category: General Payments
- Program years: PY2021–2024
- Record count: 33
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $126.33 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $126.33 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $47.26 | 2 |
| Acerta Pharma LLC | $29.45 | 2 |
| ITI, Inc. | $17.43 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.23 | 1 |
| Novo Nordisk AS | $15.96 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100228584 | Novo Nordisk Inc | $15.96 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104529294 | AstraZeneca Pharmaceuticals LP | $13.31 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105538223 | AstraZeneca Pharmaceuticals LP | $16.14 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114435303 | Exact Sciences Corporation | $22.21 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114435306 | Exact Sciences Corporation | $25.05 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137848240 | Takeda Pharmaceuticals U.S.A., Inc. | $16.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143632877 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.43 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.